Bayer CEO Defiant on Monsanto as Roundup Cancer Suits Multiply
- Baumann says Bayer ‘fully committed’ to integrating Monsanto
- Appeal against damages award likely to take ‘a year or longer’
Photographer: Jasper Juinen/Bloomberg
This article is for subscribers only.
Bayer AG Chief Executive Officer Werner Baumann said the company is “fully committed” to integrating recent acquisition Monsanto Co. despite a $289 million jury award and rising wave of lawsuits seeking to link its weed-killer Roundup with cancer.
There is “an awful lot of excitement and enthusiasm” at Bayer about the $66 billion Monsanto purchase, Baumann said on a conference call Thursday. He reiterated that the company believes the jury decision is “wrong” and “inconsistent with the robust science-based conclusions of regulators and health authorities worldwide.”